Int J Thyroidol.  2020 Nov;13(2):150-154. 10.11106/ijt.2020.13.2.150.

Pediatric Quality of Life in Congenital Hypothyroidism: an Indonesian Study

• Rochmah N
• Faizi M
• Dewanti C
• Suryawan A

• KMID: 2509196
• DOI: http://doi.org/10.11106/ijt.2020.13.2.150

Abstract

Background and Objectives
Thyroxine is important for brain development. Improper hypothyroid treatment may lead to cognitive and motor impairment, thereby affecting the quality of life. We analyzed the correlation between age at first treatment, length of treatment, initial levothyroxine (LT4) dose, and serum levels of free thyroxine (fT4) and thyroid stimulating hormone (TSH) and pediatric quality of life in patients with congenital hypothyroidism (CH). Materials and Methods: This research was a cross-sectional study of 41 children with CH who consumed LT4 for at least 3 months during March 2019-December 2019. The quality of life was assessed from parents’ reports using the Pediatric Quality of Life Inventory (PedsQL) generic scale. Spearman correlation analysis was carried out, and statistical significance was set at p＜0.05.
Results
A total of 17 of the 41 children were girls. The mean PedsQL scores in physical and psychosocial functioning were 78.12 (68.75-100) and 233.30 (215-251.67), respectively. Age at first treatment was correlated with physical functioning (r=−0.501, p＜0.05) and psychosocial functioning (r=−0.440, p＜0.05). The initial LT4 dose was negatively correlated with physical functioning (r=−0.568, p＜0.05) and psychosocial functioning (r=−0.482, p＜0.05). The length of treatment showed a positive correlation with physical functioning (r=0.776, p＜0.05) and psychosocial functioning (r= −0.852, p＜0.05). However, the serum fT4 and TSH levels were not correlated with quality of life in children with CH (p＞0.05).
Conclusion
Age at first treatment, initial dose of LT4, and length of treatment were correlated with quality of life in children with CH.

Keyword

Congenital hypothyroidism; Child; Quality of life; PedsQL

Reference

References

1. Gaitonde DY, Rowley KD, Sweeney LB. 2012; Hypothyroidism: an update. Am Fam Physician. 86(3):244–51. DOI: 10.1080/20786204.2012.10874256. PMID: 22962987.

2. Counts D, Varma SK. 2009; Hypothyroidism in children. Pediatr Rev. 30(7):251–8. DOI: 10.1542/pir.30-7-251. PMID: 19570923.

3. Bhattacharya A. 2013; Congenital hypothyroidism and developmental difficulties. Gen Med Open Access. 1(1):1–4. DOI: 10.4172/2327-5146.1000103.

4. Rahmani K, Yarahmadi S, Etemad K, Koosha A, Mehrabi Y, Aghang N, et al. 2016; Congenital hypothyroidism: optimal initial dosage and time of initiation of treatment: a systematic review. Int J Endocrinol Metab. 14(3):e36080. DOI: 10.5812/ijem.36080. PMID: 27942261. PMCID: PMC5136456.

5. Olivieri A, Fazzini C, Medda E. Italian Study Group for Congenital Hypothyroidism. 2015; Multiple factors influencing the incidence of congenital hypothyroidism detected by neonatal screening. Horm Res Paediatr. 83(2):86–93. DOI: 10.1159/000369394. PMID: 25572470.

6. Kaye CI, La Franchi S, Lane PA, Northrup H, et al. Committee on Genetics; Accurso F. 2006; Introduction to the newborn screening fact sheets. Pediatrics. 118(3):1304–12. DOI: 10.1542/peds.2006-1782. PMID: 16960984.

7. Keshavarzian E, Valipoor AA, Maracy MR. 2016; The incidence of congenital hypothyroidism and its determinants from 2012 to 2014 in Shadegan, Iran: a case-control study. Epidemiol Health. 38:e2016021. DOI: 10.4178/epih.e2016021. PMID: 27283138. PMCID: PMC4967912.

8. Ahmad A, Wasim A, Hussain S, Saeed M, Ahmad BM, Rehman KU. 2017; Congenital hypothyroidism in neonates of a tertiary care hospital. Pak J Med Sci. 33(5):1269–72. DOI: 10.12669/pjms.335.12986. PMID: 29142577. PMCID: PMC5673746.

9. Indonesian Ministry of Health. 2016. Oct. 03. Ministreal Decree no.78 issued on 2014. [Internet]. Available from URL: http://kesga.kemkes.go.id. cited January 11, 2020.

10. Indonesian Ministry of Health. 2014. Skrining Hipotiroid Kongenital. Indonesian Ministry of Health;Jakarta: p. 1–66.

11. Pulungan AB, Oldenkamp ME, van Trotsenburg ASP, Windarti W, Gunardi H. 2019; Effect of delayed diagnosis and treatment of congenital hypothyroidism on intelligence and quality of life : an observational study. Med J Ind. 28(4):396–401. DOI: 10.13181/mji.v28i4.3473.

12. Varni JW, Burwinkle TM, Seid M. 2005; The PedsQL as a pediatric patient-reported outcome: reliability and validity of the PedsQL Measurement Model in 25,000 children. Expert Rev Pharmacoecon Outcomes Res. 5(6):705–19. DOI: 10.1586/14737167.5.6.705. PMID: 19807613.

13. Varni JW. 2020. Measurement model for the pediatric quality of life inventory. [Internet]. Available from URL: http://pedsql.org. cited May 26, 2020.

14. Soghier L, Pham K, Rooney S. 2014. Reference range values for pediatric care. American Academy of Pediatrics;United State: p. 97.

15. Huang SA. Kappy MS, Allen DB, Geffner ME, editors. 2010. Thyroid. Pediatric practice endocrinology. 1st ed. Mc Graw Hill;New York: p. 107–29.

16. Bongers-Schokking JJ, Koot HM, Wiersma D, Verkerk PH, de Muinck Keizer-Schrama SM. 2000; Influence of timing and dose of thyroid hormone replacement on development in infants with congenital hypothyroidism. J Pediatr. 136(3):292–7. DOI: 10.1067/mpd.2000.103351. PMID: 10700683.

17. Ordooei M, Mottaghipisheh H, Fallah R, Rabiee A. 2014; Cognitive outcomes for congenital hypothyroid and healthy children: a comparative study. Iran J Child Neurol. 8(4):28–32. PMID: 25657767. PMCID: PMC4307365.

18. Hanley P, Lord K, Bauer AJ. 2016; Thyroid disorders in children and adolescents: a review. JAMA Pediatr. 170(10):1008–19. DOI: 10.1001/jamapediatrics.2016.0486. PMID: 27571216.

19. Jacob H, Peters C. 2015; Screening, diagnosis and management of congenital hypothyroidism: European Society for Paediatric Endocrinology consensus guideline. Arch Dis Child Educ Pract Ed. 100(5):260–3. DOI: 10.1136/archdischild-2014-307738. PMID: 25776656.

20. Rovet J. 2005; Congenital hypothyroidism: treatment and outcome. Curr Opin Endocrinol Diabetes Obes. 12:42–52. DOI: 10.1097/01.med.0000152669.91427.73.

21. Park ES, Yoon JY. 2019; Factors associated with permanent hypothyroidism in infants with congenital hypothyroidism. BMC Pediatr. 19(1):453. DOI: 10.1186/s12887-019-1833-8. PMID: 31752783. PMCID: PMC6873549.

22. Soliman AT, Azzam S, Elawwa A, Saleem W, Sabt A. 2012; Linear growth and neurodevelopmental outcome of children with congenital hypothyroidism detected by neonatal screening: a controlled study. Indian J Endocrinol Metab. 16(4):565–8. DOI: 10.4103/2230-8210.98012. PMID: 22837917. PMCID: PMC3401757.

23. Bongers-Schokking JJ, Resing WCM, Oostdijk W, de Rijke YB, de Muinck Keizer-Schrama S. 2018; Relation between early over- and undertreatment and behavioural problems in preado-lescent children with congenital hypothyroidism. Horm Res Paediatr. 90(4):247–56. DOI: 10.1159/000494056. PMID: 30408796. PMCID: PMC6492506.

24. Kooistra L, Vulsma T, van der Meere J. 2004; An investigation of impulsivity in children with early-treated congenital hypothy-roidism. Dev Neuropsychol. 26(2):595–610. DOI: 10.1207/s15326942dn2602_4. PMID: 15456686.

25. Selva KA, Harper A, Downs A, Blasco PA, Lafranchi SH. 2005; Neurodevelopmental outcomes in congenital hypothyroidism: comparison of initial T4 dose and time to reach target T4 and TSH. J Pediatr. 147(6):775–80. DOI: 10.1016/j.jpeds.2005.07.024. PMID: 16356430.

26. Salerno M, Militerni R, Bravaccio C, Micillo M, Capalbo D, Di MS, et al. 2002; Effect of different starting doses of levothyroxine on growth and intellectual outcome at four years of age in congenital hypothyroidism. Thyroid. 12(1):45–52. DOI: 10.1089/105072502753451968. PMID: 11838730.

27. Rovet JF, Ehrlich R. 2000; Psychoeducational outcome in children with early-treated congenital hypothyroidism. Pediatrics. 105(3 Pt 1):515–22. DOI: 10.1542/peds.105.3.515. PMID: 10699102.

28. Alvarez M, Iglesias Fernandez C, Rodriguez Sanchez A, Dulin Lniguez E, Rodriguez Arnao MD. 2010; Episodes of overtreatment during the first six months in children with congenital hypothyroidism and their relationships with sustained attention and inhibitory control at school age. Horm Res Paediatr. 74(2):114–20. DOI: 10.1159/000313370. PMID: 20395659.

29. Craven M, Frank GR. 2018; Does initial dosing of levothyroxine in infants with congenital hypothyroidism lead to frequent dose adjustments secondary to iatrogenic hyperthyroidism on follow-up? J Pediatr Endocrinol Metab. 31(6):597–600. DOI: 10.1515/jpem-2017-0513. PMID: 29715192.

30. Vaidyanathan P, Pathak M, Kaplowitz PB. 2012; In congenital hypothyroidism, an initial L-thyroxine dose of 10-12 mug/kg/day is sufficient and sometimes excessive based on thyroid tests 1 month later. J Pediatr Endocrinol Metab. 25(9-10):849–52. DOI: 10.1515/jpem-2012-0025. PMID: 23426811.

31. Sanjay S. 2019; Congenital hypothyroidism. IntechOpen. 6–15. DOI: 10.1016/j.clp.2017.10.004. PMID: 29405999.

32. Klaver EI, van Loon HC, Stienstra R, Links TP, Keers JC, Kema IP, et al. 2013; Thyroid hormone status and health-related quality of life in the LifeLines cohort study. Thyroid. 23(9):1066–73. DOI: 10.1089/thy.2013.0017. PMID: 23530992. PMCID: PMC3770241.

33. Kelderman-Bolk N, Visser TJ, Tijssen JP, Berghout A. 2015; Quality of life in patients with primary hypothyroidism related to BMI. Eur J Endocrinol. 173(4):507–15. DOI: 10.1530/EJE-15-0395. PMID: 26169304.

34. Ahmed ME, Elsaayed W, Ali R, Mohamed M. 2019; Developmental outcomes in early-treated congenital hypothyroidism: specific concern in Tc99m thyroid scan role. Int J Pediatr. 7(6):9631–43.

35. van der Sluijs Veer L, Kempers MJ, Last BF, Vulsma T, Grootenhuis MA. 2008; Quality of life, developmental milestones, and self-esteem of young adults with congenital hypothyroidism diagnosed by neonatal screening. J Clin Endocrinol Metab. 93(7):2654–61. DOI: 10.1210/jc.2007-1560. PMID: 18460566.

36. Razavi Z, Yavarikia A, Torabian S. 2012; Congenital anomalies in infant with congenital hypothyroidism. Oman Med J. 27(5):364–7. DOI: 10.5001/omj.2012.92. PMID: 23074545. PMCID: PMC3472568.